Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVIA Centaur EBV-VCA IgM

K-Number: K233606 · 2024-08-07

ApplicantBiokit, S.A.
Decision Date2024-08-07
Product CodeLSE
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

ADVIA Centaur EBV-VCA IgM is a medical device manufactured by Biokit, S.A.. It received FDA 510(k) clearance on 2024-08-07 under approval number K233606. The device is classified under product code LSE. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVIA Centaur EBV-VCA IgM?

ADVIA Centaur EBV-VCA IgM is a medical device that received FDA 510(k) clearance on 2024-08-07. It is manufactured by Biokit, S.A.. The 510(k) number is K233606.

When was ADVIA Centaur EBV-VCA IgM approved by the FDA?

ADVIA Centaur EBV-VCA IgM received FDA 510(k) clearance on 2024-08-07, under approval number K233606.

What company makes ADVIA Centaur EBV-VCA IgM?

ADVIA Centaur EBV-VCA IgM is manufactured by Biokit, S.A..

What is the FDA product code for ADVIA Centaur EBV-VCA IgM?

The FDA product code for ADVIA Centaur EBV-VCA IgM is LSE.

Other Devices by Biokit, S.A.

View all 8 devices →

Related Devices (Code: LSE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.